Medical News

RSS

A breakthrough in coronary bypass surgery: AMT Medical’s SAFE-CAB results published in The Journal of Thoracic and Cardiovascular Surgery

AMT Medical B.V., a clinical-stage Dutch medical technology company, today announced that the one-year results of the SAFE-CAB II clinical trial have been published in The Journal of Thoracic and Cardiovascular Surgery.

17 Jul 2026

Bundibugyo Virus Disease outbreak

As of 14 July, 2,093 confirmed cases of Bundibugyo Virus Disease and 798 deaths had been reported in the DRC and Uganda. A total of 394 people have recovered.

17 Jul 2026

Scientists discover master regulator gene network behind complex psychiatric disorders

A study by the University of Barcelona has identified nearly 20 genes that could contribute to some people being more susceptible to depression, anxiety and traits such as irritability and neuroticism.

17 Jul 2026

COVID lockdown babies show language strengths at age four

Research from the BICYCLE study shows 4-year-olds born in lockdown excel in language but face challenges in executive function, indicating a need for support.

17 Jul 2026

Dexamphetamine and methylphenidate work similarly for ADHD but differ in weight effects

A head-to-head trial of ADHD treatments finds dexamphetamine and methylphenidate equally effective, with notable differences in weight management over time.

17 Jul 2026

Diet helps people lose weight regardless of genetic obesity risk

A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging genetic determinism in weight loss.

17 Jul 2026

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX platform across India.

From DNA Script 17 Jul 2026

BYK Strengthens its portfolio of measurement and testing instruments through a strategic acquisition in the autonomous driving market

BYK-Gardner USA, a subsidiary of the specialty chemicals group ALTANA, is acquiring perisens GmbH.

From Paul N. Gardner Company 17 Jul 2026

Maternal diets high in UPFs may influence children’s health years later

A narrative review of 84 publications links higher ultra-processed food intake during pregnancy and early childhood with poorer diet quality, maternal complications, childhood obesity, and potential immune, metabolic, and neurodevelopmental effects. The authors identify possible microbiome and biopsychosocial pathways but emphasize that the predominantly observational evidence cannot establish causality.

17 Jul 2026

A wife’s account reveals the hidden burden of young-onset Alzheimer’s caregiving

Karina Acton Reid recounts caring for her husband with young-onset Alzheimer’s disease presenting as posterior cortical atrophy while raising two young children. Her perspective shows how visual disorientation, diagnostic delays, changing family roles, and inadequate age-appropriate support affect the entire household.

16 Jul 2026

Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge

Higher baseline plasma p-tau217 was associated with greater 5- and 10-year risks of cognitive impairment and faster cognitive decline among 2,684 cognitively unimpaired adults. Very high levels corresponded to an estimated 38% risk at five years, but selected cohorts and limited long-term data mean routine screening and individualized prediction remain premature.

16 Jul 2026

Timing of regenerative cues may be key to better healing from injury

For decades, medicine has chased a simple but elusive goal of delivering the right drug to the right place at the right time.

16 Jul 2026

Experimental drug shows promise against NRAS-driven melanoma

A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a groundbreaking pathway-targeted therapy could be an effective treatment for certain melanoma patients and fill an unmet clinical need for patients with advanced disease.

16 Jul 2026

New approach enhances radiotherapy by disabling cancer's DNA repair machinery

Cancer treatments like radiation and chemotherapy work by doing one main thing: shredding the DNA of cancer cells so they can no longer multiply.

16 Jul 2026

LIG1 loss reveals new treatment strategy for aggressive breast cancer

Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but researchers at Baylor College of Medicine and collaborating institutions have identified a vulnerability in these cells and used it to their advantage.

16 Jul 2026

New guideline offers recommendations for testosterone replacement therapy use

The Society's Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices.

16 Jul 2026

Researchers identify new genetic pathway driving epilepsy and seizures

Researchers have uncovered a novel biological pathway that can lead to seizures when disrupted. The findings also provide a new approach to improve the diagnosis of epilepsy, for which a genetic cause cannot be found in about 50 % of individuals with the condition

16 Jul 2026

Immune pathway may promote the progression of oral precancerous lesions

Researchers at The University of Texas MD Anderson Cancer Center identified an immune pathway that may promote the progression of oral precancerous lesions into head and neck squamous cell carcinoma.

16 Jul 2026

New model improves short- and long-term disease risk prediction

Researchers developed ALADYNOULLI, a Bayesian generative model that combines longitudinal health records, age, and polygenic risk to identify reproducible disease signatures across more than 683,000 participants. In UK Biobank testing, the framework achieved stronger short- and long-term risk discrimination than established clinical scores while revealing disease subgroups and genetic associations.

16 Jul 2026

Study links expanding GLP-1 use with rising overall costs

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022.

16 Jul 2026